Cargando…
Harmonization of medical products regulation: a key factor for improving regulatory capacity in the East African Community
BACKGROUND: Limited capacity to regulate medical products is associated with circulation of products which do not meet standards of quality, safety and efficacy with negative public health and economic outcomes. This study focused on assessing the effect of the East African Community (EAC) medicines...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818747/ https://www.ncbi.nlm.nih.gov/pubmed/33478421 http://dx.doi.org/10.1186/s12889-021-10169-1 |
_version_ | 1783638903703470080 |
---|---|
author | Ndomondo-Sigonda, Margareth Miot, Jacqueline Naidoo, Shan Masota, Nelson E. Ng’andu, Brian Ngum, Nancy Kaale, Eliangiringa |
author_facet | Ndomondo-Sigonda, Margareth Miot, Jacqueline Naidoo, Shan Masota, Nelson E. Ng’andu, Brian Ngum, Nancy Kaale, Eliangiringa |
author_sort | Ndomondo-Sigonda, Margareth |
collection | PubMed |
description | BACKGROUND: Limited capacity to regulate medical products is associated with circulation of products which do not meet standards of quality, safety and efficacy with negative public health and economic outcomes. This study focused on assessing the effect of the East African Community (EAC) medicines regulatory harmonization initiative on the capacity of national medicines regulatory agencies, with a focus on registration and inspection systems. METHODS: An exploratory mixed-method design using both qualitative and quantitative data to access data from six national medicines regulatory authorities (NMRAs) and the EAC Secretariat. Data was collected using a combination of semi-structured interviews, questionnaires, and checklists for the period 2010/11–2015/16 with 2010/11 data serving as baseline. Heads of NMRAs, regulatory and monitoring and evaluation experts, and the EAC Secretariat Project Officer were enrolled in the study. A set of 14 indicators grouped into 6 categories were used to assess NMRAs performance. RESULTS: Policy and legal frameworks provide a foundation for effective regulation. Collaboration, harmonization, joint dossier reviews and inspections of manufacturing sites, reliance and cooperation are key factors for building trust and capacity among NMRAs. Five out of six of the EAC Partner States have comprehensive medicines laws with autonomous NMRAs. All the NMRAs have functional registration and good manufacturing practice inspection systems supported by regional harmonised guidelines for registration, inspection, quality management and information management systems with four NMRAs attaining ISO 9001:2015 certification. CONCLUSIONS: The EAC regulatory harmonization initiative has contributed to improved capacity to regulate medical products. The indicators generated from this research can be replicated for evaluation of similar initiatives across and beyond the African continent and contribute to public health policy. |
format | Online Article Text |
id | pubmed-7818747 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-78187472021-01-22 Harmonization of medical products regulation: a key factor for improving regulatory capacity in the East African Community Ndomondo-Sigonda, Margareth Miot, Jacqueline Naidoo, Shan Masota, Nelson E. Ng’andu, Brian Ngum, Nancy Kaale, Eliangiringa BMC Public Health Research Article BACKGROUND: Limited capacity to regulate medical products is associated with circulation of products which do not meet standards of quality, safety and efficacy with negative public health and economic outcomes. This study focused on assessing the effect of the East African Community (EAC) medicines regulatory harmonization initiative on the capacity of national medicines regulatory agencies, with a focus on registration and inspection systems. METHODS: An exploratory mixed-method design using both qualitative and quantitative data to access data from six national medicines regulatory authorities (NMRAs) and the EAC Secretariat. Data was collected using a combination of semi-structured interviews, questionnaires, and checklists for the period 2010/11–2015/16 with 2010/11 data serving as baseline. Heads of NMRAs, regulatory and monitoring and evaluation experts, and the EAC Secretariat Project Officer were enrolled in the study. A set of 14 indicators grouped into 6 categories were used to assess NMRAs performance. RESULTS: Policy and legal frameworks provide a foundation for effective regulation. Collaboration, harmonization, joint dossier reviews and inspections of manufacturing sites, reliance and cooperation are key factors for building trust and capacity among NMRAs. Five out of six of the EAC Partner States have comprehensive medicines laws with autonomous NMRAs. All the NMRAs have functional registration and good manufacturing practice inspection systems supported by regional harmonised guidelines for registration, inspection, quality management and information management systems with four NMRAs attaining ISO 9001:2015 certification. CONCLUSIONS: The EAC regulatory harmonization initiative has contributed to improved capacity to regulate medical products. The indicators generated from this research can be replicated for evaluation of similar initiatives across and beyond the African continent and contribute to public health policy. BioMed Central 2021-01-21 /pmc/articles/PMC7818747/ /pubmed/33478421 http://dx.doi.org/10.1186/s12889-021-10169-1 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Ndomondo-Sigonda, Margareth Miot, Jacqueline Naidoo, Shan Masota, Nelson E. Ng’andu, Brian Ngum, Nancy Kaale, Eliangiringa Harmonization of medical products regulation: a key factor for improving regulatory capacity in the East African Community |
title | Harmonization of medical products regulation: a key factor for improving regulatory capacity in the East African Community |
title_full | Harmonization of medical products regulation: a key factor for improving regulatory capacity in the East African Community |
title_fullStr | Harmonization of medical products regulation: a key factor for improving regulatory capacity in the East African Community |
title_full_unstemmed | Harmonization of medical products regulation: a key factor for improving regulatory capacity in the East African Community |
title_short | Harmonization of medical products regulation: a key factor for improving regulatory capacity in the East African Community |
title_sort | harmonization of medical products regulation: a key factor for improving regulatory capacity in the east african community |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818747/ https://www.ncbi.nlm.nih.gov/pubmed/33478421 http://dx.doi.org/10.1186/s12889-021-10169-1 |
work_keys_str_mv | AT ndomondosigondamargareth harmonizationofmedicalproductsregulationakeyfactorforimprovingregulatorycapacityintheeastafricancommunity AT miotjacqueline harmonizationofmedicalproductsregulationakeyfactorforimprovingregulatorycapacityintheeastafricancommunity AT naidooshan harmonizationofmedicalproductsregulationakeyfactorforimprovingregulatorycapacityintheeastafricancommunity AT masotanelsone harmonizationofmedicalproductsregulationakeyfactorforimprovingregulatorycapacityintheeastafricancommunity AT ngandubrian harmonizationofmedicalproductsregulationakeyfactorforimprovingregulatorycapacityintheeastafricancommunity AT ngumnancy harmonizationofmedicalproductsregulationakeyfactorforimprovingregulatorycapacityintheeastafricancommunity AT kaaleeliangiringa harmonizationofmedicalproductsregulationakeyfactorforimprovingregulatorycapacityintheeastafricancommunity |